Yaodong Zhou

3PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 11, 2026
Simplified perioperative serplulimab and chemotherapy for resectable squamous NSCLC: a phase II trial with biomarker analysis.

|Sep 23, 2022
LncRNA H19 Promotes Lung Adenocarcinoma Progression via Binding to Mutant p53 R175H.

Yaodong Zhou, Qing Xia

|Apr 14, 2020
Inhibition of LncRNAH19 has the effect of anti-tumour and enhancing sensitivity to Gefitinib and Chemotherapy in Non-small-cell lung cancer in vivo.

Yaodong Zhou, Yixin Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Yihua Sun

1 joint publications

Haiquan Chen